IP Library Patent Application 11495102
Patent Application
App. No. 11/495,102

Process for the preparation of intermediates of perindopril

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/495,102
Abstract

A process for the preparation of (2S, 3aS, 7aS)perhydroindole-2-carboxylic acid is provided comprising (a) esterifying a cis-perhydroindole-2-carboxylic acid with a first alcohol of the formula ROH and a suitable free acid to provide the acid salt (AS) of Formula V: (b) reacting the acid salt of Formula V with a first base to provide a compound of Formula VI: (c) treating the product of step (b) with an L-tartaric containing acid in a second alcohol of the formula ROH to precipitate a compound of Formula VII: (d) reacting the compound of Formula VII with a second base to provide a compound of Formula II (e) hydrolyzing the compound of Formula II to provide the (2S, 3aS, 7aS)perhydroindole-2-carboxylic acid.

Claims (30)

1 . A process for the preparation of (2S,3aS,7aS)perhydroindole-2-carboxylic acid of Formula III

the process comprising:

(a) esterifying cis-perhydroindole-2-carboxylic acid of Formula IV:

with a first alcohol of the formula ROH and a suitable free acid to provide the acid salt (AS) of formula V:

wherein R is an alkyl, aryl or aralkyl group;

(b) reacting the acid salt of Formula V with a first base to provide a compound of Formula VI:

(c) treating the product of step (b) with an L-tartaric containing acid in a second alcohol of the formula ROH to precipitate a compound of Formula VII:

wherein R has the aforestated meaning;

(d) reacting the compound of Formula VII with a second base to provide a compound of Formula II

wherein R has the aforestated meaning; and

(e) hydrolyzing the compound of Formula II to provide the compound of Formula III.

2 . The process of claim 1 , wherein the first alcohol is benzyl alcohol.

3 . The process of claim 1 , wherein the first alcohol is selected from the group consisting of methanol, ethanol, isopropanol, propanol, butanol and mixtures thereof.

4 . The process of claim 1 , wherein the free acid is selected from the group consisting of p-toluenesulfonic acid, hydrochloric acid and mixtures thereof.

5 . The process of claim 1 , wherein the first base is organic amine base.

6 . The process of claim 1 , wherein the first base is selected from the group consisting of a primary amine, secondary amine, tertiary amine, aliphatic amine, aromatic amine, ammonia and mixtures thereof.

7 . The process of claim 1 , wherein the first base is selected from the group consisting of a tertiary amine, heterocyclic amine and mixtures thereof.

8 . The process of claim 1 , wherein the first base is selected from the group consisting of a trialkylamine, heterocyclic amine and mixtures thereof.

9 . The process of claim 8 , wherein the trialkylamine contains from about 3 to about 20 carbon atoms.

10 . The process of claim 1 , wherein the first base is selected from the group consisting of trimethylamine, triethylamine, tripropylamine, tributylamine and mixtures thereof.

11 . The process of claim 1 , wherein the first base is selected from the group consisting of an alkali metal carbonate, alkali earth metal carbonate and mixtures thereof.

12 . The process of claim 1 , wherein the first base is selected from the group consisting of sodium carbonate, potassium carbonate and mixtures thereof.

13 . The process of claim 1 , wherein the L-tartaric containing acid is dibenzoyl L-tartaric acid or L-tartaric acid.

14 . The process of claim 1 , wherein the second alcohol is benzyl alcohol.

15 . The process of claim 1 , wherein the second alcohol is selected from the group consisting of methanol, ethanol, isopropanol, propanol, butanol and mixtures thereof.

16 . The process of claim 1 , wherein the second base is selected from the group consisting of an alkali metal hydroxide, alkali earth metal hydroxide and mixtures thereof.

17 . The process of claim 1 , wherein the second base is selected from the group consisting of sodium hydroxide, potassium hydroxide and mixtures thereof.

18 . The process of claim 1 , wherein in step (e) the compound of Formula II is hydrolyzed with an alkali metal hydroxide.

19 . The process of claim 1 , wherein the compound of Formula III is thereafter converted to perindopril or a pharmaceutically acceptable salt thereof.

20 . Perindopril erbumine obtained from the process of claim 19.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2008
From: GLENMARK PHARMACEUTICALS LTD.
To: GLENMARK GENERICS LTD.
Reel/Frame 020733/0397 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2006
From: JOSHI, NARENDRA SHRIRAM; RAMAM, BUDDHAVARAPU PATTABHI; BODKHE, ARJUN RAJARAM
To: GLENMARK PHARMACEUTICALS LIMITED
Reel/Frame 018251/0055 →